Nexentis Technologies Inc. (NXTS) stock
NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.82−0.17 (-8.42%)
Close on Nov 17, 2026Market cap $2.65MP/E –Yield –
Nexentis Technologies operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Nexentis Technologies's operating cash flow for the twelve months ending Jun 30, 2026 was -$4.43M. For fiscal 2025 it was -$3.81M. The highest annual figure on record is -$506.50K in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$3.81M | – |
| FY2024 | Dec 31, 2024 | -$3.42M | – |
| FY2023 | Dec 31, 2023 | -$3.23M | – |
| FY2022 | Dec 31, 2022 | -$5.10M | – |
| FY2021 | Dec 31, 2021 | -$4.11M | – |
| FY2020 | Dec 31, 2020 | -$798.74K | – |
| FY2019 | Dec 31, 2019 | -$1.24M | – |
| FY2018 | Dec 31, 2018 | -$506.50K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$539.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.42M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.50M | – |
| Q3 FY2025 | Sep 30, 2025 | -$974.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$528.00K | – |
| Q1 FY2025 | Mar 31, 2025 | -$809.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$492.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$891.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.03M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.01M | – |
| Q4 FY2023 | Dec 31, 2023 | -$975.13K | – |
| Q3 FY2023 | Sep 30, 2023 | -$624.45K | – |
| Q2 FY2023 | Jun 30, 2023 | -$528.63K | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.11M | – |
| Q4 FY2022 | Dec 31, 2022 | -$970.42K | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.77M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.27M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.09M | – |
| Q4 FY2021 | Dec 31, 2021 | -$923.40K | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.47M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.63M | – |
| Q1 FY2021 | Mar 31, 2021 | -$84.55K | – |
| Q4 FY2020 | Dec 31, 2020 | -$179.34K | – |
| Q3 FY2020 | Sep 30, 2020 | -$150.40K | – |
| Q2 FY2020 | Jun 30, 2020 | -$235.36K | – |
| Q1 FY2020 | Mar 31, 2020 | -$233.64K | – |
| Q4 FY2019 | Dec 31, 2019 | -$364.99K | – |
| Q3 FY2019 | Sep 30, 2019 | -$285.10K | – |
| Q2 FY2019 | Jun 30, 2019 | -$267.78K | – |
| Q1 FY2019 | Mar 31, 2019 | -$326.89K | – |
See a number that looks wrong?